National Cancer Institute; Notice of Closed Meetings, 10519-10520 [2019-05334]

Download as PDF amozie on DSK9F9SC42PROD with NOTICES Federal Register / Vol. 84, No. 55 / Thursday, March 21, 2019 / Notices • Retitle the Office of Analysis and Epidemiology (CPCB) to the Division of Analysis and Epidemiology (CPCB). II. Under Part C, Section C–B, Organization and Functions, make the following change: • Division of Analysis and Epidemiology (CPCB). (1) Participates in the development of policy, long-range plans, and programs of the Center, with emphasis on advancing the use of Center data systems; (2) plans, directs, and coordinates the Analysis and Epidemiology Program of the Center; (3) conducts developmental and evaluation research and analysis in the areas of epidemiology, health status, health services utilization, health promotion, and health economics, including methodological issues related to conceptualization and measurement; (4) provides leadership and expertise in the application of statistical techniques to integrate, analyze and report data from multiple and diverse sources; (5) provides consultation and technical assistance to the Center, CDC, the Department and other public and private health agencies at the national and international level on activities on the analysis and interpretation of health statistics; (6) augments the methodological and policy analysis activities of the Center; and (7) focuses on complex methods, analyses, and tools that integrate health data from diverse sources, including research on measurement, linkage, and surveillance of population health and health promotion. • Health Promotion Statistics Branch (CPCBB). (1) Develops policies, plans, and strategies for the implementation of surveillance and data systems in support of the Department’s health promotion and disease prevention objectives; (2) coordinates the health promotion and disease prevention related data collection activities of the Center; (3) serves as liaison with the Department’s Office of Disease Prevention and Health Promotion; (4) provides support and technical assistance to state and local health agencies in the areas of statistical assessment and the use of data for policy development and program planning; (5) coordinates Center activities that assess the progress on the elimination of health disparities; (6) establishes consensus-building processes involving CDC, the Department, state and local agencies, and the private sector to identify priority data gaps on national health promotion objectives and recommends solutions to fill these gaps; and (7) designs, develops, and implements computer data processing systems and VerDate Sep<11>2014 18:27 Mar 20, 2019 Jkt 247001 software and produces statistical data for analysis. • Measures Research and Evaluation Branch (CPCBD). (1) Develops and conducts a research program designed to examine significant public health problems, as well as the sources of data available and needed to inform their use in the evaluation of population health initiatives both in the U.S. and internationally; (2) uses statistical data from multiple sources, with an emphasis on Center data and the measures used to collect data for major areas of programmatic interest; (3) conducts multi-disciplinary research focusing on population health and functioning to examine areas of interest including methodological issues related to conceptualization and measurement; (4) collaborates with, and provides leadership, consultation and technical assistance to, others within the Center, the Federal government and internationally; and (5) prepares research and analytic reports for publication and dissemination. • Data Linkage Methodology and Analysis Branch (CPCBE). (1) Plans, directs, and manages the Center’s multifaceted methodological research program on major public health issues including data linkage and geocoding activities; (2) develops and executes center-wide data linkage and geocoding activities to collect additional information to maximize the scientific value of the Center’s population-based cross-sectional and longitudinal health surveys while maintaining respondent confidentiality; (3) develops, plans, and implements studies evaluating the methodology used for the Center’s data linkage projects; (4) provides leadership and expert consultation to the Center’s data divisions on best practices and methodologies used for data linkage; (5) provides consultation and technical assistance to the research community utilizing the NCHS survey linked data files; and (6) prepares methodological and research reports for publication and dissemination to support the Center’s data linkage projects. • Population Health Reporting and Dissemination Branch (CPCBG). (1) Serves as a focal point for a Center-wide analytical program aimed at the assessment and development of health data from multiple sources designed to facilitate the analysis of population health and emerging public health issues; (2) conducts and coordinates indepth statistical analyses of special population groups relating to their health characteristics and their health care needs; (3) directs preparation of the Secretary’s annual report, Health, United States, on the health status of the PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 10519 Nation to the President and the Congress in compliance with Section 308 of the PHS Act and other recurring and special reports requested by the Department; (4) provides leadership and expertise in the application of sophisticated statistical techniques related to the problem of integrating, analyzing, and reporting data from diverse sources; and (5) conducts research on selected aspects of health status and health services for publication and dissemination. IV. Delegations of Authority: All delegations and redelegations of authority made to officials and employees of affected organizational components will continue in them or their successors pending further redelegation, provided they are consistent with this reorganization. (Authority: 44 U.S.C. 3101). Alex M. Azar II, Secretary. [FR Doc. 2019–05365 Filed 3–20–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Physical Sciences-Oncology. Date: May 9, 2019. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center E:\FR\FM\21MRN1.SGM 21MRN1 10520 Federal Register / Vol. 84, No. 55 / Thursday, March 21, 2019 / Notices Drive, Room 7W254, Bethesda, MD 20892– 9750, 240–276–7975, chufanee@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–9: NCI Clinical and Translational R21 and Omnibus R03. Date: May 22, 2019. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Bethesda, MD 20892– 9750, 240–276–6349, ahmads@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: March 15, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–05334 Filed 3–20–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health amozie on DSK9F9SC42PROD with NOTICES National Eye Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Eye Institute Special Emphasis Panel, April 2, 2019, 2:00 p.m. to April 2, 2019, 4:00 p.m., National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817 which was published in the Federal Register on March 14, 2019, 84– 9365. The meeting notice is amended to change the date of the meeting from April 2, 2019 to April 5, 2019 the meeting is closed to the public. Dated: March 15, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–05335 Filed 3–20–19; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:27 Mar 20, 2019 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Psycho/Neuropathology Lifespan Development, STEM Education. Date: April 15, 2019. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elia E. Femia, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301–827–7189, femiaee@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 15, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–05332 Filed 3–20–19; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the Fmt 4703 Dated: March 18, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–05414 Filed 3–20–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Sfmt 4703 Agency Information Collection Activities: Customs-Trade Partnership Against Terrorism (C–TPAT) and the Trusted Trader Program U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day Notice and request for comments; Extension of an existing collection of information. AGENCY: National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Frm 00045 Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Trials in Diabetes. Date: April 3, 2019. Time: 9:00 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–8886, sanoviche@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) [1651–0077] BILLING CODE 4140–01–P PO 00000 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request SUMMARY: E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 84, Number 55 (Thursday, March 21, 2019)]
[Notices]
[Pages 10519-10520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-05334]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Physical Sciences-Oncology.
    Date: May 9, 2019.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center

[[Page 10520]]

Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
chufanee@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-9: NCI Clinical and Translational R21 and Omnibus R03.
    Date: May 22, 2019.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W102, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
ahmads@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 15, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-05334 Filed 3-20-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.